US2019322427A1PendingUtilityA1
Pharmaceutical formulation
Est. expiryAug 14, 2022(expired)· nominal 20-yr term from priority
Inventors:Brian Whittle
A61P 9/10A61P 37/06A61P 29/00A61P 25/08A61P 25/14A61P 3/04A61P 25/00A61P 3/00A61P 1/00A61K 9/006B65D 65/38B65B 31/00A61K 31/352A61K 36/185A61K 31/05A61K 36/3482A61K 31/658
68
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to pharmaceutical formulations, and more particularly to formulations containing cannabinoids for administration via a pump action spray. In particular, the invention relates to pharmaceutical formulations, for use in administration of lipophilic medicaments via mucosal surfaces, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant.
Claims
exact text as granted — not AI-modified1 . A liquid pharmaceutical formulation, for use in administration of a lipophilic medicament via a mucosal surface, comprising: at least one lipophilic medicament, a solvent and a co-solvent, wherein the total amount of solvent and co-solvent present in the formulation is greater than 55% wt/wt of the formulation and the formulation is absent of a self emulsifying agent and/or a fluorinated propellant.
2 .- 79 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.